No Picture
Trading Ideas

PG&E Pushes Newsom For Plan to Fund Bankruptcy With Bonds

(Bloomberg) — PG&E Corp. is pushing California Governor Gavin Newsom to support a proposal by the utility to issue billions of dollars in bonds backed by customer bills to help pay for its bankruptcy plan, according to people familiar with the matter.The effort to win the governor’s support comes as PG&E has a Friday deadline to file its $46 billion restructuring plan with state regulators. Newsom’s office hasn’t signed off on the idea of using bonds, the people said.The proposal is one of the final issues the two sides are debating as PG&E pushes to emerge from the largest utility …read more […]

No Picture
Business News

U.S.-UK trade deal needs labor, climate protections, enforcement: U.S. lawmaker

A future U.S.-UK trade agreement must incorporate strong provisions on worker rights, environmental protection, and enforcement to ensure bipartisan support, U.S. House Ways and Means Committee Chairman Richard Neal said on Friday, staking out a claim for Congress to help shape any such accord.

…read more […]

No Picture
Business News

China’s Tianjin closes schools, firms until further notice to curb virus: state media

The northern Chinese city of Tianjin has ordered schools and non-essential companies to remain closed until further notice to curb the spread of the coronavirus that has already infected thousands in the country, a local government-run newspaper said.

…read more […]

No Picture
Business News

Future U.S.-UK trade deal needs labor, climate protections, enforcement: U.S. lawmaker

A future U.S.-UK trade agreement must incorporate strong provisions on worker rights, environmental protection, and enforcement to ensure bipartisan support, U.S. House Ways and Means Committee Chairman Richard Neal said on Friday, staking out a claim for Congress to help shape any such accord.

…read more […]

No Picture
Trading Ideas

First Peanut Allergy Drug Wins Approval From U.S. Regulators

(Bloomberg) — U.S. health regulators approved the first drug for children and teenagers with peanut allergies, marking a potential paradigm shift in treatment.The drug, which will be sold under the brand name Palforzia, will be marketed by Aimmune Therapeutics Inc.. The therapy involves ingesting small doses of peanut protein, gradually increased over time to help desensitize patients to higher levels. The medicine is similar to oral therapies offered by some allergists; however, it is the first to be cleared by the U.S. Food and Drug Administration.Shares of Aimmune jumped 22% in extended trading Friday to $37.90 a share. The stock …read more […]